Cargando…

An Investigation of Fecal Volatile Organic Metabolites in Irritable Bowel Syndrome

Diagnosing irritable bowel syndrome (IBS) can be a challenge; many clinicians resort to invasive investigations in order to rule out other diseases and reassure their patients. Volatile organic metabolites (VOMs) are emitted from feces; understanding changes in the patterns of these VOMs could aid o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahmed, Iftikhar, Greenwood, Rosemary, Costello, Ben de Lacy, Ratcliffe, Norman M., Probert, Chris S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3596408/ https://www.ncbi.nlm.nih.gov/pubmed/23516449 http://dx.doi.org/10.1371/journal.pone.0058204

Ejemplares similares

Investigation of urinary volatile organic compounds as novel diagnostic and surveillance biomarkers of bladder cancer
por: Lett, Lauren, et al.
Publicado: (2022)

Urinary Volatile Organic Compounds for the Detection of Prostate Cancer
por: Khalid, Tanzeela, et al.
Publicado: (2015)

Hyphenated Mass Spectrometry versus Real-Time Mass Spectrometry Techniques for the Detection of Volatile Compounds from the Human Body
por: Gould, Oliver, et al.
Publicado: (2021)

Towards the Identification of Antibiotic-Resistant Bacteria Causing Urinary Tract Infections Using Volatile Organic Compounds Analysis—A Pilot Study
por: Hewett, Keith, et al.
Publicado: (2020)

Using Volatile Organic Compounds to Investigate the Effect of Oral Iron Supplementation on the Human Intestinal Metabolome
por: Ahmed, Ammar, et al.
Publicado: (2020)

The fecal mycobiome in patients with Irritable Bowel Syndrome
por: Das, A., et al.
Publicado: (2021)

Simultaneous fecal microbial and metabolite profiling enables accurate classification of pediatric irritable bowel syndrome
por: Shankar, Vijay, et al.
Publicado: (2015)

An Optimization of Liquid–Liquid Extraction of Urinary Volatile and Semi-Volatile Compounds and Its Application for Gas Chromatography-Mass Spectrometry and Proton Nuclear Magnetic Resonance Spectroscopy
por: Drabińska, Natalia, et al.
Publicado: (2020)

A Pilot Study Combining a GC-Sensor Device with a Statistical Model for the Identification of Bladder Cancer from Urine Headspace
por: Khalid, Tanzeela, et al.
Publicado: (2013)

Frequency of Abnormal Fecal Biomarkers in Irritable Bowel Syndrome
por: Goepp, Julius, et al.
Publicado: (2014)

Volatile organic compounds emitted from faeces as a biomarker for colorectal cancer
por: Bond, Ashley, et al.
Publicado: (2019)

Fecal microbiota profiling in irritable bowel syndrome and inflammatory bowel disease patients with irritable bowel syndrome-type symptoms
por: Cui, Xiufang, et al.
Publicado: (2021)

Assessing the chemotaxis behavior of Physarum polycephalum to a range of simple volatile organic chemicals
por: de Lacy Costello, Ben P.J., et al.
Publicado: (2013)

Analysis of brain networks and fecal metabolites reveals brain–gut alterations in premenopausal females with irritable bowel syndrome
por: Osadchiy, Vadim, et al.
Publicado: (2020)

Fecal and Mucosal Microbiota Profiling in Irritable Bowel Syndrome and Inflammatory Bowel Disease
por: Lo Presti, Alessandra, et al.
Publicado: (2019)

Effects of Rifaximin on Transit, Permeability, Fecal Microbiome, and Organic Acid Excretion in Irritable Bowel Syndrome
por: Acosta, Andrés, et al.
Publicado: (2016)

Gas Chromatography Mass Spectrometry (GC-MS) Quantification of Metabolites in Stool Using (13)C Labelled Compounds
por: Gould, Oliver, et al.
Publicado: (2018)

Urinary Volatile Organic Compound Testing in Fast-Track Patients with Suspected Colorectal Cancer
por: Boulind, Caroline E., et al.
Publicado: (2022)

Can fecal microbiota transplantation cure irritable bowel syndrome?
por: Halkjær, Sofie Ingdam, et al.
Publicado: (2017)

Is fecal calprotectin always normal in children with irritable bowel syndrome?
por: Choi, You Jin, et al.
Publicado: (2019)

Oral and fecal microbiota in patients with diarrheal irritable bowel syndrome
por: Tang, Binbin, et al.
Publicado: (2023)

Diagnosis and treatment of diarrhea-predominant irritable bowel syndrome
por: Lacy, Brian E
Publicado: (2016)

Fecal Microbiota Signatures Are Not Consistently Related to Symptom Severity in Irritable Bowel Syndrome
por: Wang, Taojun, et al.
Publicado: (2022)

Freeze-drying: an alternative method for the analysis of volatile organic compounds in the headspace of urine samples using solid phase micro-extraction coupled to gas chromatography - mass spectrometry
por: Aggio, Raphael B. M., et al.
Publicado: (2016)

Volatile organic compound profiling as a potential biomarker in irritable bowel syndrome: A feasibility study
por: Van Malderen, Kathleen, et al.
Publicado: (2022)

Fecal Microbiota Alterations Associated With Diarrhea-Predominant Irritable Bowel Syndrome
por: Zhuang, Xiaojun, et al.
Publicado: (2018)

Research Progress in Fecal Microbiota Transplantation as Treatment for Irritable Bowel Syndrome
por: Wang, Yao, et al.
Publicado: (2019)

Gut Microbiota-Derived Metabolites in Irritable Bowel Syndrome
por: Xiao, Lin, et al.
Publicado: (2021)

Altered profiles of fecal metabolites correlate with visceral hypersensitivity and may contribute to symptom severity of diarrhea-predominant irritable bowel syndrome
por: Zhang, Wen-Xue, et al.
Publicado: (2019)

Irritable bowel syndrome: Is it “irritable brain” or “irritable bowel”?
por: Padhy, Susanta Kumar, et al.
Publicado: (2015)

Rome Criteria and a Diagnostic Approach to Irritable Bowel Syndrome
por: Lacy, Brian E., et al.
Publicado: (2017)

Fecal microbiota transplantation for irritable bowel syndrome: An intervention for the 21(st) century
por: El-Salhy, Magdy, et al.
Publicado: (2021)

Genetic and phenotypic diversity of fecal Candida albicans strains in irritable bowel syndrome
por: van Thiel, Isabelle A. M., et al.
Publicado: (2022)

Irritable bowel syndrome patients who are not likely to respond to fecal microbiota transplantation
por: El‐Salhy, Magdy, et al.
Publicado: (2022)

Changes in fecal short‐chain fatty acids following fecal microbiota transplantation in patients with irritable bowel syndrome
por: El‐Salhy, Magdy, et al.
Publicado: (2020)

Safety of Eluxadoline in Patients with Irritable Bowel Syndrome with Diarrhea
por: Cash, Brooks D, et al.
Publicado: (2017)

Differentiating Coeliac Disease from Irritable Bowel Syndrome by Urinary Volatile Organic Compound Analysis – A Pilot Study
por: Arasaradnam, Ramesh P., et al.
Publicado: (2014)

ORGANIC GASTROINTESTINAL ILLNESS AND THE IRRITABLE BOWEL SYNDROME
por: Rajagopalan, Mani
Publicado: (1995)

Fecal calprotectin: a marker for clinical differentiation of microscopic colitis and irritable bowel syndrome
por: von Arnim, Ulrike, et al.
Publicado: (2016)

Fecal microbiota transplantation for patients with irritable bowel syndrome: A meta-analysis protocol
por: Wen, Wenting, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_2g4ucrjfronofroiavkklgq9qd